SOL J BARER Insider Trading $CELG CELGENE CORP /DE/
Get free email notifications about insider trading for SOL J BARER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SOL J BARER. SOL J BARER is Chief Operating Officer in CELGENE CORP /DE/ ($CELG) and Director in TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) and Director in AMICUS THERAPEUTICS INC ($FOLD) and Director in MEDGENICS, INC. ($MDGN) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in InspireMD, Inc. ($NSPR) and Director in CONTRAFECT Corp ($CFRX) and Director in NexImmune, Inc. ($NEXI) and Director in Cerecor Inc. ($CERC).
SOL J BARER in CELGENE CORP /DE/
Trading Symbol: CELGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SOL J BARER: Chief Operating Officer
Holdings: 228,568 shares
Current Value: $26,573,316
Latest Transaction: Nov 13 2003
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SOL J BARER in CELGENE CORP /DE/
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, GNMX, FOLD, CELG, CERC, CFRX, NSPR, NEXI, EDGE, TEVA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 13 2003 | CELG | CELGENE CORP /DE/ | BARER SOL J | Chief Operating Off ... | Option Exercise | A | 2.50 | 10,000 | 25,000 | 0 | |
Nov 13 2003 | CELG | CELGENE CORP /DE/ | BARER SOL J | Chief Operating Off ... | Buy | M | 2.50 | 10,000 | 25,000 | 228,568 | 218.6 K to 228.6 K (+4.58 %) |
Page: 1